Mary C. Dunlay

403 total citations
7 papers, 313 citations indexed

About

Mary C. Dunlay is a scholar working on Cardiology and Cardiovascular Medicine, Infectious Diseases and Small Animals. According to data from OpenAlex, Mary C. Dunlay has authored 7 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Cardiology and Cardiovascular Medicine, 1 paper in Infectious Diseases and 1 paper in Small Animals. Recurrent topics in Mary C. Dunlay's work include Blood Pressure and Hypertension Studies (2 papers), Heart Failure Treatment and Management (2 papers) and Veterinary Pharmacology and Anesthesia (1 paper). Mary C. Dunlay is often cited by papers focused on Blood Pressure and Hypertension Studies (2 papers), Heart Failure Treatment and Management (2 papers) and Veterinary Pharmacology and Anesthesia (1 paper). Mary C. Dunlay collaborates with scholars based in United States. Mary C. Dunlay's co-authors include Allan I. Goldberg, Charles S. Sweet, Peter H. Vlasses, Lair G.T. Ribeiro, M Hichens, Alice E. Loper, Joseph V. Bondi, Roger K. Ferguson, Heschi H. Rotmensch and Bertram Pitt and has published in prestigious journals such as Journal of Medicinal Chemistry, The American Journal of Cardiology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Mary C. Dunlay

7 papers receiving 285 citations

Peers

Mary C. Dunlay
JC Petrie United Kingdom
P. F. Binnion United States
Adrianne Anderson Australia
Suzanne Oparil United States
Neal Klein United States
Steve Whitebread Switzerland
Takeshi Hata Japan
L. Jordö Sweden
Maurizio Destro Italy
G Betzien Germany
JC Petrie United Kingdom
Mary C. Dunlay
Citations per year, relative to Mary C. Dunlay Mary C. Dunlay (= 1×) peers JC Petrie

Countries citing papers authored by Mary C. Dunlay

Since Specialization
Citations

This map shows the geographic impact of Mary C. Dunlay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary C. Dunlay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary C. Dunlay more than expected).

Fields of papers citing papers by Mary C. Dunlay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary C. Dunlay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary C. Dunlay. The network helps show where Mary C. Dunlay may publish in the future.

Co-authorship network of co-authors of Mary C. Dunlay

This figure shows the co-authorship network connecting the top 25 collaborators of Mary C. Dunlay. A scholar is included among the top collaborators of Mary C. Dunlay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary C. Dunlay. Mary C. Dunlay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Pitt, Bertram, Paul Chang, William Grossman, Mary C. Dunlay, & Pieter B.M.W.M. Timmermans. (1996). Rationale, background, and design of the randomized angiotensin receptor antagonist—Angiotensin-converting enzyme inhibitor study (RAAS). The American Journal of Cardiology. 78(10). 1129–1131. 20 indexed citations
2.
3.
Goldberg, Allan I., Mary C. Dunlay, & Charles S. Sweet. (1995). Safety and tolerability of losartan compared with atenolol, felodipine and angiotensin converting enzyme inhibitors. Journal of Hypertension. 13(Supplement 1). S77–S80. 20 indexed citations
4.
Dunlay, Mary C., et al.. (1995). Losartan potassium as initial therapy in patients with severe hypertension.. PubMed. 9(11). 861–7. 18 indexed citations
5.
Vlasses, Peter H., Lair G.T. Ribeiro, Heschi H. Rotmensch, et al.. (1985). Initial Evaluation of Transdermal Timolol. Journal of Cardiovascular Pharmacology. 7(2). 245–250. 39 indexed citations
6.
Bicking, John B., et al.. (1983). 11,12-Secoprostaglandins. 6. Interphenylene analogs of acylhydroxyalkanoic acids and related compounds as renal vasodilators. Journal of Medicinal Chemistry. 26(3). 335–341. 3 indexed citations
7.
Dunlay, Mary C., et al.. (1981). Renal function during consciousness and anesthesia in sheep: effects of renal vasodilation by papaverine and acetylcholine.. Journal of Pharmacology and Experimental Therapeutics. 218(2). 470–474. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by JC Petrie Breakdown of academic impact, for papers by P. F. Binnion Breakdown of academic impact, for papers by Adrianne Anderson Breakdown of academic impact, for papers by Suzanne Oparil Breakdown of academic impact, for papers by Neal Klein Breakdown of academic impact, for papers by Steve Whitebread Breakdown of academic impact, for papers by Takeshi Hata Breakdown of academic impact, for papers by L. Jordö Breakdown of academic impact, for papers by Maurizio Destro Breakdown of academic impact, for papers by G Betzien
Rankless by CCL
2026